Researchers Discover Four New Lysolipin Compounds with Antibacterial and Anticancer Properties
Scientists isolated four previously unreported lysolipin analogues (J–M) from a soil-derived Streptomyces bacterium, expanding a rare class of bioactive xanthone compounds. Lysolipins I, J, and K showed strong activity against Staphylococcus aureus and the fungus Aspergillus flavus, as well as potent cytotoxicity against prostate cancer cell lines at submicromolar concentrations. However, the compounds' broad, non-selective bioactivity limits their immediate therapeutic applicability.
A research team studying the soil bacterium Streptomyces sp. P8-2B18 identified a putative lysolipin biosynthetic gene cluster and used LC-MS metabolomics to detect both the known compound lysolipin I and several unreported analogues. Large-scale fermentation and isolation yielded four new structures—lysolipins J, K, L, and M—whose chemical architectures were determined through mass spectrometry and NMR spectroscopy. Lysolipin L is structurally notable for containing a five-membered lactam F ring not previously seen in this compound class, while lysolipin M features an extra methyl group and a glycosyl substituent in place of a 1,3-oxane ring, giving it a novel skeleton. Antimicrobial testing showed lysolipins I, J, and K to be potent against Staphylococcus aureus and Aspergillus flavus, with minimum inhibitory concentrations between 0.25 and 4 µg/mL, whereas lysolipin L was only moderately active and lysolipin M was essentially inactive. In cytotoxicity assays against prostate cancer lines LNCaP and C4-2B, lysolipins I–K achieved IC50 values in the submicromolar range, lysolipin L showed no cytotoxicity, and lysolipin M showed substantially reduced potency. These structure-activity findings clarify which structural features are essential for bioactivity but also highlight that the compounds' lack of selectivity remains a barrier to therapeutic development.
What's missing
The study does not report selectivity indices or cytotoxicity data against non-cancerous cell lines, which would be needed to assess therapeutic windows. Mechanistic data explaining how these compounds exert antibacterial or cytotoxic effects are also absent.
What different sources said
- bioRxivCenter
Antimicrobial and Cytotoxic Lysolipins I-M Isolated from Streptomyces sp. P8-2B18
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.